Loading...

NUTX NUTEX HEALTH INC Management Changes 8-K Filing

NTX

NTX

NUTEX HEALTH INC

(NUTX)

2025 8-K

Summary

Summary

New COO Appointment

Legal Action Filed

Board Appointment

Securities Class Action

Delisting Notice

Financial Update

Financial Statements

Financial Results

Arbitration Update

Financial Results

Financial Results Announcement

Compliance Notice from Nasdaq

Reverse Stock Split

Delisting Notice

Financial Results

Reverse Stock Split

Appointment of Director

Financial Results Announcement

Departure and Appointment o...

Termination of Agreement

Salary Reduction

Securities Purchase Agreement

Presentation at Conference

Financial Results Announcement

Appointment of Chief Operat...

Acquisition of Companies

Financial Results Announcement

Delisting Notice

Financial Results

Regulation FD Disclosure

Pre-Paid Advance Agreement

Departure and Appointment o...

Financial Results and Valua...

Regulation FD Disclosure

Stock Option Cancellation

External Links:

On September 4, 2025, Nutex Health, Inc. announced the appointment of Michael L. Reed as Lead Independent Director, effective September 2, 2025. This move enhances corporate governance and complies with Nasdaq's requirements for independent leadership.

AI Assistant

NUTEX HEALTH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.